These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 22648766)
1. Candidate diseases for prenatal gene therapy. David AL; Waddington SN Methods Mol Biol; 2012; 891():9-39. PubMed ID: 22648766 [TBL] [Abstract][Full Text] [Related]
2. Organ targeted prenatal gene therapy--how far are we? Mehta V; Abi Nader K; Waddington S; David AL Prenat Diagn; 2011 Jul; 31(7):720-34. PubMed ID: 21618255 [TBL] [Abstract][Full Text] [Related]
3. The sheep model of in utero gene therapy. Porada CD; Park P; Almeida-Porada G; Zanjani ED Fetal Diagn Ther; 2004; 19(1):23-30. PubMed ID: 14646413 [TBL] [Abstract][Full Text] [Related]
4. Gene therapy progress and prospects: fetal gene therapy--first proofs of concept--some adverse effects. Coutelle C; Themis M; Waddington SN; Buckley SM; Gregory LG; Nivsarkar MS; David AL; Peebles D; Weisz B; Rodeck C Gene Ther; 2005 Nov; 12(22):1601-7. PubMed ID: 16136161 [TBL] [Abstract][Full Text] [Related]
5. Monitoring for potential adverse effects of prenatal gene therapy: use of large animal models with relevance to human application. Mehta V; Abi-Nader KN; Carr D; Wallace J; Coutelle C; Waddington SN; Peebles D; David AL Methods Mol Biol; 2012; 891():291-328. PubMed ID: 22648778 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy for the fetus: is there a future? David AL; Peebles D Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):203-18. PubMed ID: 17900991 [TBL] [Abstract][Full Text] [Related]
7. Vector systems for prenatal gene therapy: choosing vectors for different applications. Coutelle C; Waddington SN Methods Mol Biol; 2012; 891():41-53. PubMed ID: 22648767 [TBL] [Abstract][Full Text] [Related]
8. In utero gene therapy: current challenges and perspectives. Waddington SN; Kramer MG; Hernandez-Alcoceba R; Buckley SM; Themis M; Coutelle C; Prieto J Mol Ther; 2005 May; 11(5):661-76. PubMed ID: 15851005 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia. Colvin J; Bower C; Dickinson JE; Sokol J Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678 [TBL] [Abstract][Full Text] [Related]
10. Fetal muscle gene therapy/gene delivery in large animals. Abi-Nader KN; David AL Methods Mol Biol; 2011; 709():239-56. PubMed ID: 21194032 [TBL] [Abstract][Full Text] [Related]
11. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo. Themis M Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780 [TBL] [Abstract][Full Text] [Related]
12. Animal models for prenatal gene therapy: choosing the right model. Mehta V; Peebles D; David AL Methods Mol Biol; 2012; 891():183-200. PubMed ID: 22648773 [TBL] [Abstract][Full Text] [Related]
13. Animal models for prenatal gene therapy: the nonhuman primate model. Mattar CN; Biswas A; Choolani M; Chan JK Methods Mol Biol; 2012; 891():249-71. PubMed ID: 22648776 [TBL] [Abstract][Full Text] [Related]
14. Stem cell and genetic therapies for the fetus. Roybal JL; Santore MT; Flake AW Semin Fetal Neonatal Med; 2010 Feb; 15(1):46-51. PubMed ID: 19540822 [TBL] [Abstract][Full Text] [Related]
15. Fetal gene therapy: opportunities and risks. Wagner AM; Schoeberlein A; Surbek D Adv Drug Deliv Rev; 2009 Aug; 61(10):813-21. PubMed ID: 19426772 [TBL] [Abstract][Full Text] [Related]
16. Fetal and neonatal gene therapy: benefits and pitfalls. Waddington SN; Kennea NL; Buckley SM; Gregory LG; Themis M; Coutelle C Gene Ther; 2004 Oct; 11 Suppl 1():S92-7. PubMed ID: 15454963 [TBL] [Abstract][Full Text] [Related]
17. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]